CLINICAL_TRIALS
trial_result
· 2019-08-12
Clinical Trial Update: A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma [Phase 1]
Summary
Phase 1 clinical trial update of olaratumab (LY3012207) in participants with soft tissue sarcoma has completed, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2019-08-12